Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Glukos Gel is a rapid-acting oral carbohydrate formulation containing glucose (dextrose) used for the emergency treatment of hypoglycemia, particularly in individuals with diabetes mellitus. The gel is designed for quick administration and rapid absorption, either through the oral mucosa or upon swallowing, to provide an immediate increase in blood sugar levels. By raising the concentration of glucose in the systemic circulation, it restores the primary energy source for the brain and other vital organs, thereby reversing symptoms such as confusion, dizziness, and tremors associated with low blood glucose. It is typically packaged in single-use tubes or sachets for ease of use during a hypoglycemic crisis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Glukos Gel.